[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NicDaéid et al., 2012 - Google Patents

Using isotopic fractionation to link precursor to product in the synthesis of (±)-mephedrone: a new tool for combating “legal high” drugs

NicDaéid et al., 2012

View PDF
Document ID
9081954537455439417
Author
NicDaéid N
Meier-Augenstein W
Kemp H
Sutcliffe O
Publication year
Publication venue
Analytical chemistry

External Links

Snippet

Several recent deaths in the UK have been attributed to “legal high” drugs and in particular to (±)-4-methylmethcathinone ((±)-mephedrone). Recent literature has begun to focus on the chemical analysis of mephedrone and related substituted cathinones and methcathinones; …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8665—Signal analysis for calibrating the measuring apparatus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Similar Documents

Publication Publication Date Title
NicDaéid et al. Using isotopic fractionation to link precursor to product in the synthesis of (±)-mephedrone: a new tool for combating “legal high” drugs
Webster et al. Expanding the analytical toolbox: pharmaceutical application of quantitative NMR
Shin et al. Simultaneous determination of 75 abuse drugs including amphetamines, benzodiazepines, cocaine, opioids, piperazines, zolpidem and metabolites in human hair samples using liquid chromatography–tandem mass spectrometry
Adnani et al. Universal quantification of structurally diverse natural products using an evaporative light scattering detector
Hassanien et al. In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis
Marchei et al. Ultra-high performance liquid chromatography-high resolution mass spectrometry and high-sensitivity gas chromatography-mass spectrometry screening of classic drugs and new psychoactive substances and metabolites in urine of consumers
Salouros et al. Measurement of stable isotope ratios in methylamphetamine: a link to its precursor source
Pagliano et al. Negative chemical ionization GC/MS determination of nitrite and nitrate in seawater using exact matching double spike isotope dilution and derivatization with triethyloxonium tetrafluoroborate
Hussain et al. Quantification of MDMA in seized tablets using benchtop 1H NMR spectroscopy in the absence of internal standards
Mano et al. HPLC with fluorescence detection assay of perampanel, a novel AMPA receptor antagonist, in human plasma for clinical pharmacokinetic studies
Leeming et al. High-resolution twin-ion metabolite extraction (HiTIME) mass spectrometry: Nontargeted detection of unknown drug metabolites by isotope labeling, liquid chromatography mass spectrometry, and automated high-performance computing
El‐Shaheny Evaluation of agomelatine stability under different stress conditions using an HPLC method with fluorescence detection: application to the analysis of tablets and human plasma
Meermann et al. HPLC/ICP-MS in combination with “reverse” online isotope dilution in drug metabolism studies
Ferretti et al. Development of a high‐performance liquid chromatography method for the simultaneous determination of chiral impurities and assay of (S)‐clopidogrel using a cellulose‐based chiral stationary phase in methanol/water mode
Pinto et al. Topiramate: a review of analytical approaches for the drug substance, its impurities and pharmaceutical formulations
Vay et al. Quantification of microdosed oral yohimbine and its major metabolite in human plasma in the picogram range
Pasham et al. Separation and quantification of organic‐related impurities of beta‐adrenergic receptor blocking agent propranolol in pharmaceutical solid dosage forms: Impurity profiling using stability‐indicating HPLC method
Boppy et al. Stability‐indicating liquid chromatography method development for assay and impurity profiling of amitriptyline hydrochloride in tablet dosage form and forced degradation study
Moorthy et al. Development and validation of LC–QTOF–MS/MS method for the identification and determination of low levels of a genotoxic impurity, 4, 6‐dichloro‐5‐nitro‐2‐(propylthio) pyrimidine in ticagrelor API
Treitler et al. Mutagenic impurities in 1-hydroxybenzotriazole (HOBt)
Toker et al. A new HPLC method with fluorescence detection for the determination of memantine in human plasma
Zheng et al. Hydrogen–deuterium scrambling based on chemical isotope labeling coupled with LC–MS: Application to amine metabolite identification in untargeted metabolomics
Coulerie et al. Standardized LC× LC-ELSD fractionation procedure for the identification of minor bioactives via the enzymatic screening of natural extracts
Gonçalves et al. Synthesis, Characterization, and Comparative 32P-Postlabeling Efficiencies of 2, 6-Dimethylaniline− DNA Adducts
Pinciroli et al. The well-characterized synthetic molecule: a role for quantitative 1H NMR